🔎 Trials Near Me

Home › Kanser sa Bato (Renal Cell Carcinoma) › Ohio › Cleveland

Pag-aaral pangklinika para sa Kanser sa Bato (Renal Cell Carcinoma) sa Cleveland, OH

14 pag-aaral para sa Kanser sa Bato (Renal Cell Carcinoma) ang naghahanap ng mga kalahok sa mga site sa loob at paligid ng Cleveland (sa loob ng humigit-kumulang 30 milya). Buksan ang pag-aaral upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

A Phase 1 Study of AB521 Monotherapy and Combination Therapies in Renal Cell Carcinoma and Other Solid Tumors

Nagre-recruitPhase 1
  • Research Site, Cleveland
  • Research Site, Cleveland
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 5, 2026 · NCT05536141

Open-Label Phase 1/2 Study of NEO-811 in Subjects With Locally Advanced or Metastatic Non-Resectable Clear Cell Renal Cell Carcinoma

Nagre-recruitPhase 1
  • NEO-811 Cleveland Site, Cleveland
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 5, 2026 · NCT07300241

A Study of HC-7366 in Combination With Belzutifan (WELIREG™) in Patients With Renal Cell Carcinoma

Nagre-recruitPhase 1
  • University Hospitals Cleveland Medical Center, Cleveland
  • Cleveland Clinic, Cleveland
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT06234605

Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors

Nagre-recruitPhase 1
  • Exelixis Clinical Site #10, Cleveland
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 1, 2026 · NCT05176483

Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectable or Metastatic Renal Cell Cancer, SAMURAI Trial

Nagre-recruitPhase 2
  • Case Western Reserve University, Cleveland
  • UHHS-Chagrin Highlands Medical Center, Beachwood · 10 mi ang layo
  • UH Seidman Cancer Center at Lake Health Mentor Campus, Mentor · 22 mi ang layo
Edad 18 pataas · Lahat ng kasarian · Na-update Set 18, 2026 · NCT05327686

ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation

Nagre-recruitObservasyonal na pag-aaral
  • Cleveland Clinic, Cleveland
Edad 18 pataas · Lahat ng kasarian · Na-update Set 14, 2026 · NCT05059444

Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab) After Surgery to Remove All Known Sites of Kidney Cancer

Nagre-recruitPhase 3
  • Case Western Reserve University, Cleveland
  • UHHS-Chagrin Highlands Medical Center, Beachwood · 10 mi ang layo
  • UH Seidman Cancer Center at Lake Health Mentor Campus, Mentor · 22 mi ang layo
Edad 18 pataas · Lahat ng kasarian · Na-update Set 2, 2026 · NCT06661720

Genetic Testing to Select Therapy for the Treatment of Advanced or Metastatic Kidney Cancer, OPTIC RCC Study

Nagre-recruitPhase 2
  • University Hospitals Seidman Cancer Center, Cleveland
  • Cleveland Clinic, Cleveland
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 19, 2026 · NCT05361720

Study of DCC-2812 in Participants With Advanced Genitourinary Cancers

Nagre-recruitPhase 1
  • Cleveland Clinic, Cleveland
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 18, 2026 · NCT06966024

A Study of the c-Kit Specific Antibody-Drug Conjugate NN3201 for Advanced and/or Metastatic Solid Tumors Known to Express c-Kit

Nagre-recruitPhase 1
  • Case Comprehensive Cancer Center, Cleveland
Edad 18 pataas · Lahat ng kasarian · Na-update Set 23, 2025 · NCT06805825

Comparing the Outcome of Immunotherapy-Based Drug Combination Therapy With or Without Surgery to Remove the Kidney in Metastatic Kidney Cancer, the PROBE Trial

Nagre-recruitPhase 3
  • Case Western Reserve University, Cleveland
  • UHHS-Chagrin Highlands Medical Center, Beachwood · 10 mi ang layo
  • UH Seidman Cancer Center at Lake Health Mentor Campus, Mentor · 22 mi ang layo
Edad 18 pataas · Lahat ng kasarian · Na-update Set 9, 2025 · NCT04510597

Pag-aaral para sa Kanser sa Bato (Renal Cell Carcinoma) sa ibang lungsod

Iba pang pag-aaral sa Cleveland

Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.